StonvexLoading…
StonvexStonvexStonvexCore line items from MIRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $159.88M | $521.31M | $372.38M | $239.37M |
Operating Income | $-789.47M | $-22.14M | $-17.57M | $-20.17M |
Net Income | $-790.15M | $-23.36M | $-17.63M | $-5.86M |
EPS (Diluted) | $-13.43 | $-0.47 | $-0.35 | $-0.42 |
Total Assets | $890.92M | $842.81M | $785.12M | $725.83M |
Total Liabilities | $648.42M | $528.12M | $493.07M | $470.67M |
Cash & Equivalents | $324.91M | $296.68M | $282.02M | $228.12M |
Free Cash Flow OCF − CapEx | $-229.43M | $54.87M | $49.41M | $9.91M |
Shares Outstanding | 60.93M | 51.90M | 51.31M | 50.06M |